Hologic (HOLX) Competitors $62.10 -0.82 (-1.30%) Closing price 05/30/2025 04:00 PM EasternExtended Trading$60.90 -1.20 (-1.92%) As of 05/30/2025 07:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock HOLX vs. EW, IDXX, RMD, DXCM, STE, PODD, BAX, MASI, GMED, and TFXShould you be buying Hologic stock or one of its competitors? The main competitors of Hologic include Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), ResMed (RMD), DexCom (DXCM), STERIS (STE), Insulet (PODD), Baxter International (BAX), Masimo (MASI), Globus Medical (GMED), and Teleflex (TFX). These companies are all part of the "health care equipment" industry. Hologic vs. Edwards Lifesciences IDEXX Laboratories ResMed DexCom STERIS Insulet Baxter International Masimo Globus Medical Teleflex Edwards Lifesciences (NYSE:EW) and Hologic (NASDAQ:HOLX) are both large-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, profitability, analyst recommendations, dividends, earnings, risk, community ranking, media sentiment and valuation. Is EW or HOLX more profitable? Edwards Lifesciences has a net margin of 72.93% compared to Hologic's net margin of 18.42%. Hologic's return on equity of 19.72% beat Edwards Lifesciences' return on equity.Company Net Margins Return on Equity Return on Assets Edwards Lifesciences72.93% 19.40% 14.37% Hologic 18.42%19.72%10.94% Does the MarketBeat Community favor EW or HOLX? Edwards Lifesciences received 458 more outperform votes than Hologic when rated by MarketBeat users. Likewise, 70.77% of users gave Edwards Lifesciences an outperform vote while only 69.04% of users gave Hologic an outperform vote. CompanyUnderperformOutperformEdwards LifesciencesOutperform Votes134170.77% Underperform Votes55429.23% HologicOutperform Votes88369.04% Underperform Votes39630.96% Which has more risk and volatility, EW or HOLX? Edwards Lifesciences has a beta of 1.12, suggesting that its stock price is 12% more volatile than the S&P 500. Comparatively, Hologic has a beta of 0.54, suggesting that its stock price is 46% less volatile than the S&P 500. Do analysts rate EW or HOLX? Edwards Lifesciences currently has a consensus target price of $80.20, indicating a potential upside of 2.70%. Hologic has a consensus target price of $77.42, indicating a potential upside of 24.66%. Given Hologic's higher possible upside, analysts clearly believe Hologic is more favorable than Edwards Lifesciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Edwards Lifesciences 1 Sell rating(s) 12 Hold rating(s) 11 Buy rating(s) 0 Strong Buy rating(s) 2.42Hologic 0 Sell rating(s) 11 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.41 Which has preferable valuation and earnings, EW or HOLX? Edwards Lifesciences has higher revenue and earnings than Hologic. Edwards Lifesciences is trading at a lower price-to-earnings ratio than Hologic, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEdwards Lifesciences$5.52B8.30$4.17B$7.0011.16Hologic$4.03B3.44$789.50M$2.3726.20 Do insiders and institutionals hold more shares of EW or HOLX? 79.5% of Edwards Lifesciences shares are owned by institutional investors. Comparatively, 94.7% of Hologic shares are owned by institutional investors. 0.3% of Edwards Lifesciences shares are owned by company insiders. Comparatively, 1.9% of Hologic shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Does the media refer more to EW or HOLX? In the previous week, Hologic had 6 more articles in the media than Edwards Lifesciences. MarketBeat recorded 30 mentions for Hologic and 24 mentions for Edwards Lifesciences. Edwards Lifesciences' average media sentiment score of 1.59 beat Hologic's score of 0.82 indicating that Edwards Lifesciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Edwards Lifesciences 23 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Hologic 16 Very Positive mention(s) 3 Positive mention(s) 6 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive SummaryEdwards Lifesciences beats Hologic on 12 of the 19 factors compared between the two stocks. Get Hologic News Delivered to You Automatically Sign up to receive the latest news and ratings for HOLX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HOLX vs. The Competition Export to ExcelMetricHologicX IndustryMedical SectorNASDAQ ExchangeMarket Cap$13.85B$11.45B$5.42B$8.41BDividend YieldN/A1.74%5.28%4.17%P/E Ratio19.5917.8727.0519.79Price / Sales3.447.76406.30134.00Price / Cash11.6911.9038.2534.64Price / Book2.922.056.744.50Net Income$789.50M$344.53M$3.23B$248.30M7 Day Performance14.41%4.06%1.22%0.99%1 Month Performance8.41%2.17%5.99%7.48%1 Year Performance-15.83%-0.37%25.78%8.72% Hologic Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HOLXHologic4.6551 of 5 stars$62.10-1.3%$77.42+24.7%-15.8%$13.85B$4.03B19.596,940Analyst ForecastShort Interest ↑High Trading VolumeEWEdwards Lifesciences4.6042 of 5 stars$74.98+0.3%$80.20+7.0%-10.2%$43.98B$5.52B10.7617,300Positive NewsAnalyst RevisionIDXXIDEXX Laboratories3.3151 of 5 stars$501.57-0.6%$536.00+6.9%+3.1%$40.34B$3.93B47.0110,800Positive NewsAnalyst DowngradeRMDResMed4.174 of 5 stars$243.03-1.0%$259.33+6.7%+18.6%$35.63B$5.02B28.698,160Positive NewsDXCMDexCom4.7871 of 5 stars$84.51-0.4%$98.00+16.0%-27.6%$33.14B$4.15B59.107,600Positive NewsAnalyst ForecastInsider TradeGap UpSTESTERIS4.6675 of 5 stars$243.21-0.2%$264.00+8.5%+10.0%$23.90B$5.46B51.6416,000Positive NewsAnalyst ForecastInsider TradeShort Interest ↓PODDInsulet4.1943 of 5 stars$321.36+0.1%$308.00-4.2%+83.1%$22.62B$2.20B55.502,600Positive NewsAnalyst ForecastBAXBaxter International4.5793 of 5 stars$30.16-0.4%$37.25+23.5%-10.6%$15.48B$10.77B-23.5660,000Short Interest ↓MASIMasimo4.1799 of 5 stars$150.13+0.1%$191.60+27.6%+29.6%$8.14B$2.13B103.546,200Positive NewsAnalyst DowngradeShort Interest ↑Analyst RevisionGMEDGlobus Medical4.8301 of 5 stars$59.00+0.7%$94.00+59.3%-11.8%$8.11B$2.51B78.662,600Analyst ForecastAnalyst RevisionTFXTeleflex4.9198 of 5 stars$120.95+0.0%$164.63+36.1%-41.6%$5.34B$3.01B24.0515,500Positive News Related Companies and Tools Related Companies Edwards Lifesciences Alternatives IDEXX Laboratories Alternatives ResMed Alternatives DexCom Alternatives STERIS Alternatives Insulet Alternatives Baxter International Alternatives Masimo Alternatives Globus Medical Alternatives Teleflex Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HOLX) was last updated on 6/1/2025 by MarketBeat.com Staff From Our PartnersDalio heeds Buffett’s warning… [$319 million stake in gold]Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profita...Golden Portfolio | SponsoredBig Oil’s big pivotThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredTrump Just Gave the Green Light to Rewrite Social Security?In a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredBanks aren’t ready for this altcoin—are you?I've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredThe “supermetal” that could power AIWhile the headlines focus on AI models and chip speed, Elon Musk is investing in the material side of the stor...True Market Insiders | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredMidnight trade alert: After-hours spike incoming??? Most traders don’t realize this… But the closing bell means jack $#!&. They hear the bell and they think...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hologic, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hologic With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy HOLX Stock Free HOLX Stock Alerts